These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25985641)

  • 21. Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer.
    Jiao F; Hu H; Yuan C; Wang L; Jiang W; Jin Z; Guo Z; Wang L
    Oncol Rep; 2014 Dec; 32(6):2485-92. PubMed ID: 25269958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
    Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
    Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of hypoxia in pancreatic cancer: a potential therapeutic target?
    Erkan M; Kurtoglu M; Kleeff J
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):301-16. PubMed ID: 26560854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental study of the function of nuclear factor-κB-dependent epithelial to mesenchymal transition in pancreatic cancer cells under hypoxic conditions].
    Cheng ZX; Sun B; Wang SJ; Zhou HX; Jia G; Kong R; Wang G; Jiang HC
    Zhonghua Wai Ke Za Zhi; 2012 May; 50(5):446-51. PubMed ID: 22883954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-gene signaling pathways in pancreatic cancer.
    Drakaki A; Iliopoulos D
    Biomed J; 2013; 36(5):200-8. PubMed ID: 24225187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications.
    Ischenko I; Seeliger H; Kleespies A; Angele MK; Eichhorn ME; Jauch KW; Bruns CJ
    Langenbecks Arch Surg; 2010 Jan; 395(1):1-10. PubMed ID: 19421768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A roadmap toward total elimination of cancer].
    Okamoto K; Nakagama H
    Nihon Rinsho; 2015 May; 73(5):860-5. PubMed ID: 25985644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cells as therapeutic targets of pancreatic cancer.
    Razi E; Radak M; Mahjoubin-Tehran M; Talebi S; Shafiee A; Hajighadimi S; Moradizarmehri S; Sharifi H; Mousavi N; Sarvizadeh M; Nejati M; Taghizadeh M; Ghasemi F
    Fundam Clin Pharmacol; 2020 Apr; 34(2):202-212. PubMed ID: 31709581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell-based targeted therapy in pancreatic cancer: Current approaches and future prospects.
    Mahadiuzzaman ASM; Dain Md Opo FA; Alkarim S
    Tissue Cell; 2024 Aug; 89():102449. PubMed ID: 38924893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical research of targeting therapy for cancer stem cells].
    Shitara K; Doi T
    Nihon Rinsho; 2015 May; 73(5):823-30. PubMed ID: 25985638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.
    Sahin IH; Iacobuzio-Donahue CA; O'Reilly EM
    Expert Opin Ther Targets; 2016; 20(3):341-59. PubMed ID: 26439702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype.
    Yee NS
    Adv Exp Med Biol; 2013; 779():91-143. PubMed ID: 23288637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic cancer: translational research aspects and clinical implications.
    Ansari D; Chen BC; Dong L; Zhou MT; Andersson R
    World J Gastroenterol; 2012 Apr; 18(13):1417-24. PubMed ID: 22509073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.
    Tanaka S
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S197-205. PubMed ID: 25749932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming drug resistance in pancreatic cancer.
    Long J; Zhang Y; Yu X; Yang J; LeBrun DG; Chen C; Yao Q; Li M
    Expert Opin Ther Targets; 2011 Jul; 15(7):817-28. PubMed ID: 21391891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell-directed therapies in pancreatic cancer.
    Kumar R; Dholakia A; Rasheed Z
    Curr Probl Cancer; 2013; 37(5):280-6. PubMed ID: 24331183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AUTS2 is a potential therapeutic target for pancreatic cancer patients with liver metastases.
    Han Y; Ru GQ; Mou X; Wang HJ; Ma Y; He XL; Yan Z; Huang D
    Med Hypotheses; 2015 Aug; 85(2):203-6. PubMed ID: 25962312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects.
    Neureiter D; Jäger T; Ocker M; Kiesslich T
    World J Gastroenterol; 2014 Jun; 20(24):7830-48. PubMed ID: 24976721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem cell markers for liver cancer and pancreatic cancer.
    Xia P; Liu DH
    Stem Cell Res; 2022 Apr; 60():102701. PubMed ID: 35149457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Holistic Approaches for Overcoming Therapy Resistance in Pancreatic and Colon Cancers.
    Sarkar FH
    Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):3-10. PubMed ID: 26228733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.